Natera Inc Stock
Price
Target price
€186.75
€186.75
-1.440%
-2.75
-1.440%
-
05.06.26 / Tradegate
WKN: A14VPJ / Name: Natera / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Natera Inc Stock
A loss of -1.440% shows a downward development for Natera Inc.
Pros and Cons of Natera Inc in the next few years
Pros
?
B****
?
S********** s********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Natera Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Natera Inc | -1.440% | -2.429% | 5.568% | 28.793% | -5.203% | 307.751% | - |
| SI-BONE Inc | -0.780% | 5.833% | 9.483% | -23.494% | -24.852% | - | - |
| Lantheus Holdings Inc | -1.130% | 2.817% | 19.346% | 24.680% | 53.147% | 7.169% | - |
| Cryolife Inc. | 0.000% | -6.283% | -41.503% | -28.685% | -54.161% | 31.618% | -24.153% |
News
Here's Billionaire Stanley Druckenmiller's Top Holding (Hint: It's Not Alphabet or Nvidia)
Your personal portfolio doesn't necessarily need to mirror a billionaire investor's holdings. But let's face it -- they manage billion-dollar portfolios for a reason.
And that's what makes Stanley
Allogene Therapeutics Q1 Earnings Call Highlights
Allogene Therapeutics (NASDAQ:ALLO) said its first quarter of 2026 was marked by early clinical progress for its lead allogeneic CAR-T programs and a
Natera Q1 Earnings Call Highlights
Natera (NASDAQ:NTRA) reported first-quarter 2026 revenue of $697 million, up 39% year over year, as the company delivered more than 1 million total units in a